- Launched a CBD direct selling initiative in China
- Marketing expert Fengxian Xie brings nearly 20 years of marketing experience to the management team of the newly established CBD Community Center
- First to offer hemp-infused skin care products in China
- Goals of maximizing shareholder value, doubling revenues and meeting qualifications for listing on the Nasdaq or NYSE
The premier financial information website for Chinese-speaking investors, ChineseInvestors.com, Inc. (OTCQB: CIIX) announced in a recent press release (http://cnw.fm/uKR8R) that it has launched a two-tiered direct selling initiative through wholly owned foreign enterprise CBD Biotechnology Co. Ltd. aimed at accelerating its CBD sales in China.
Marketing expert Fengxian Xie has joined the CBD Biotech management team, bringing nearly 20 years of marketing experience with him. Under his leadership as the president of the CBD Community Center, a new marketing channel will be established to stimulate demand for CBD Biotech’s innovative CBD infused skin care products, CBD Magic Hemp Series and the Live Oxygen luxury line.
Under Xie’s management, the CBD direct selling community will have access to seminars and expos designed for business-to-business and business-to-customer sales opportunities. Members will be compensated for product sales and receive stock-based performance bonuses. CIIX is the first to offer hemp-infused skin care products in China, and Xie will lead the way forward in expanding the community’s reach to every city in the country.
“We believe we are building the first Chinese CBD marketing community that offers our members the opportunity to become invested in the Company,” CIIX CEO Warren Wang stated in a news release. “Our efforts in advancing the CBD Community Center will involve a twofold mission: to educate the Chinese community about the benefits of hemp-infused skin care and increase product sales. We are confident that with Mr. Xie’s experience and proven track record, he is the perfect candidate to lead the development of this direct selling initiative.”
At the heart of everything CIIX does is a continued commitment to providing premier financial information, education and services to the Chinese-speaking community throughout the world. As the company makes plans to refocus back to its original mission of financial consulting and branding, it is in the process of spinning off its CBD division into its own subsidiary. Wang previously shared with MoneyTV (http://cnw.fm/BAu4d) that his goal is to maximize shareholders’ value and his hope is that the subsidiary can double its revenues and meet qualifications for listing on the Nasdaq or NYSE by next year.
For more information, visit the company’s website at www.ChineseInvestors.com
More from CannabisNewsWire
About CBDWire
CBDWire (CBDW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CBDNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
CBDWire (CBDW)
Denver, Colorado
cbdwire.com
303.498.7722 Office
Editor@CBDWire.com
